node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ENSMALP00000025327 | LOC109952337 | ENSMALP00000025327 | ENSMALP00000032489 | Insulin receptor substrate 4a. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.961 |
ENSMALP00000025327 | LOC109955690 | ENSMALP00000025327 | ENSMALP00000012032 | Insulin receptor substrate 4a. | Insulin receptor substrate 2a. | 0.912 |
ENSMALP00000025327 | LOC109959979 | ENSMALP00000025327 | ENSMALP00000025000 | Insulin receptor substrate 4a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.928 |
ENSMALP00000025327 | LOC109966482 | ENSMALP00000025327 | ENSMALP00000004087 | Insulin receptor substrate 4a. | Si:ch73-335l21.1. | 0.905 |
ENSMALP00000025327 | LOC109966709 | ENSMALP00000025327 | ENSMALP00000011329 | Insulin receptor substrate 4a. | Insulin-like growth factor 1a receptor. | 0.971 |
ENSMALP00000025327 | LOC109968712 | ENSMALP00000025327 | ENSMALP00000029823 | Insulin receptor substrate 4a. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.974 |
ENSMALP00000025327 | grb10 | ENSMALP00000025327 | ENSMALP00000027923 | Insulin receptor substrate 4a. | Growth factor receptor-bound protein 10b. | 0.467 |
ENSMALP00000025327 | grb2 | ENSMALP00000025327 | ENSMALP00000006296 | Insulin receptor substrate 4a. | Growth factor receptor-bound protein 2b. | 0.983 |
LOC109952337 | ENSMALP00000025327 | ENSMALP00000032489 | ENSMALP00000025327 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 4a. | 0.961 |
LOC109952337 | LOC109955690 | ENSMALP00000032489 | ENSMALP00000012032 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin receptor substrate 2a. | 0.961 |
LOC109952337 | LOC109959979 | ENSMALP00000032489 | ENSMALP00000025000 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.903 |
LOC109952337 | LOC109964050 | ENSMALP00000032489 | ENSMALP00000028187 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | SHC (Src homology 2 domain containing) transforming protein 2. | 0.401 |
LOC109952337 | LOC109966482 | ENSMALP00000032489 | ENSMALP00000004087 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Si:ch73-335l21.1. | 0.975 |
LOC109952337 | LOC109966709 | ENSMALP00000032489 | ENSMALP00000011329 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin-like growth factor 1a receptor. | 0.975 |
LOC109952337 | LOC109968712 | ENSMALP00000032489 | ENSMALP00000029823 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.901 |
LOC109952337 | LOC109971729 | ENSMALP00000032489 | ENSMALP00000003304 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 10a. | 0.429 |
LOC109952337 | grb10 | ENSMALP00000032489 | ENSMALP00000027923 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 10b. | 0.567 |
LOC109952337 | grb2 | ENSMALP00000032489 | ENSMALP00000006296 | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Growth factor receptor-bound protein 2b. | 0.569 |
LOC109955690 | ENSMALP00000025327 | ENSMALP00000012032 | ENSMALP00000025327 | Insulin receptor substrate 2a. | Insulin receptor substrate 4a. | 0.912 |
LOC109955690 | LOC109952337 | ENSMALP00000012032 | ENSMALP00000032489 | Insulin receptor substrate 2a. | IlGF domain-containing protein; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.961 |